We are live on
!
Find out more
MC
Martin & Co Portfolio holdings
AUM
$640M
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+21.51%
1 Year Est. Return
+23.57%
3 Year Est. Return
+67.79%
5 Year Est. Return
+76.4%
10 Year Est. Return
+289.06%
AUM
$322M
AUM Growth
+$43M
(+15%)
Cap. Flow
-$10.7M
Cap. Flow
% of AUM
-3.33%
Top 10 Holdings %
Top 10 Hldgs %
28.59%
Holding
122
New
2
Increased
68
Reduced
45
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SouthState Bank Corp
SSB
|
+$1.6M |
| 2 |
Transcat
TRNS
|
+$641K |
| 3 |
Ameris Bancorp
ABCB
|
+$446K |
| 4 |
iShares US Healthcare Providers ETF
IHF
|
+$220K |
| 5 |
Amdocs
DOX
|
+$215K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$2.11M |
| 2 |
CSFL
CenterState Bank Corporation Common Stock
CSFL
|
+$1.71M |
| 3 |
Skyworks Solutions
SWKS
|
+$1.38M |
| 4 |
Microsoft
MSFT
|
+$1.27M |
| 5 |
CVS Health
CVS
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.1% |
| 2 | Technology | 15.39% |
| 3 | Healthcare | 9.35% |
| 4 | Financials | 8.94% |
| 5 | Industrials | 6.61% |
Similar funds
AMCA
SIM
IF
KJWM
SCA
GG
FWM
AHSW
Martin & Co's Q2 2020 Portfolio in Review
As of Q2 2020, Martin & Co held 122 positions worth $322M, up 15% from $279M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Martin & Co withdrew a net $10.7M in Q2 2020, closing 5 positions and reducing 45 holdings. Its most notable exit was Bio-Rad Laboratories Class A, an estimated $2.11M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 40% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Martin & Co opened a new position in SouthState Bank Corp worth $1.46M.
- Martin & Co's largest Q2 2020 buy was SouthState Bank Corp: 30,727 shares worth $1.46M.
- Martin & Co added most to Ameris Bancorp in Q2 2020, an estimated $446K increase.
- Martin & Co's biggest Q2 2020 reduction was Skyworks Solutions, cutting an estimated $1.38M.
- Martin & Co fully exited Bio-Rad Laboratories Class A in Q2 2020, selling an estimated $2.11M.
- Martin & Co's ten largest holdings make up 29% of its $322M portfolio in Q2 2020.
- Martin & Co opened 2 new positions and closed 5 in Q2 2020.
- Martin & Co's portfolio value rose 15% quarter-over-quarter to $322M.
Based on Martin & Co's 13F filing for Q2 2020, filed 14 Aug 2020.